Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

By Natalie Morrison

- Last updated on GMT

Related tags: European union, Vp, Executive director

The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer.

Speaking to Outsourcing-Pharma.com, the firm's VP of European clinical operations and executive director of pharmacovigilance said the directive will correct the mistakes of the past that have caused a reduction of clinical trials in Europe.

When asked if it is ethical to make one market very attractive for conducting trials, she said: “I don’t think it will lead to a great influx in trials. It will be a slow development and it will make it more proportionate and more fair compared to the situation now.”

Schiefer added that if anything, the EC could have implemented more scientific expert committees looking at certain indications when forming the new guidelines.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Related suppliers

Follow us

Products

View more

Webinars